1. Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
2. Department of Microbiology and Immunology, Hearst Microbiology Research Center, Cornell University Weill Medical College, New York, New York 10021, USA
3. Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA

Correspondence to: Nikola P. Pavletich^1,3 Correspondence and requests for materials should be addressed to N.P.P. (Email: nikola@xray2.mskcc.org).

Abstract

The BRCA2 tumour suppressor¹ is essential for the error-free repair of double-strand breaks (DSBs) in DNA by homologous recombination^{2, 3}. This is mediated by RAD51, which forms a nucleoprotein filament with the 3' overhanging single-stranded DNA (ssDNA) of the resected DSB, searches for a homologous donor sequence, and catalyses strand exchange with the donor DNA⁴. The 3,418-amino-acid BRCA2 contains eight 30-amino-acid BRC repeats that bind RAD51 (refs 5, 6) and a 700-amino-acid DBD domain that binds ssDNA⁷. The isolated BRC and DBD domains have the opposing effects of inhibiting^{8, 9} and stimulating recombination⁷, respectively, and the role of BRCA2 in repair has been unclear. Here we show that a full-length BRCA2 homologue (Brh2) stimulates Rad51-mediated recombination at substoichiometric concentrations relative to Rad51. Brh2 recruits Rad51 to DNA and facilitates the nucleation of the filament, which is then elongated by the pool of free Rad51. Brh2 acts preferentially at a junction between double-stranded DNA (dsDNA) and ssDNA, with strict specificity for the 3' overhang polarity of a resected DSB. These results establish a BRCA2 function in RAD51-mediated DSB repair and explain the loss of this repair capacity in BRCA2-associated cancers.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.